Source: Health Products Regulatory Authority (ZA) Revision Year: 2024 Publisher: UNIMED HEALTHCARE (PTY) LTD, Corner Birch Road & Bluegum Avenue, Anchorville, Lenasia, 1827, South Africa, Tel: +27 11 056 6999
CLAVUMED formulations are indicated for the treatment of infections caused by amoxicillin-resistant organisms producing beta-lactamases sensitive to clavulanic acid:
CLAVUMED tablet formulation will also be effective in the treatment of infections caused by amoxicillin-sensitive organisms at the appropriate amoxicillin dosage since in this situation the clavulanic acid component does not contribute to the therapeutic effect.
For Oral Formulations
Tablets should be taken immediately before a meal.
For infections caused by amoxicillin sensitive organisms the dosage is that approved for amoxicillin as the clavulanic acid component does not contribute to the therapeutic effect.
The adult dose for CLAVUMED 375 and 625 Tablets is one CLAVUMED 375 Tablet every eight hours at the start of a meal. For more severe infections and infection of the respiratory tract, the dose should be one CLAVUMED 625 Tablet every eight hours at the start of a meal. Since CLAVUMED 375, 625 and 1 g tablets contain the same amount of clavulanic acid (125 g as the potassium salt), two CLAVUMED 375 tablets are not equivalent to one CLAVUMED 625 tablet and two CLAVUMED 625 tablets are not equivalent to one CLAVUMED 1 g. Therefore, two CLAVUMED 375 tablets should not be substituted for one CLAVUMED 625 tablet or two CLAVUMED 625 tablets for one CLAVUMED 1 g tablet for the treatment of more severe infections.
The following schedule is proposed.
Dosage guide:
Amoxicillin-Sensitive Organisms | ||||
---|---|---|---|---|
Product | Upper Respiratory Tract Infection | Lower Respiratory Tract Infection | Urinary Tract Infection | Skin & Soft Tissue Infections |
Clavumed 375 | 1 tablet 8 hourly | - | 1 tablet 8 hourly | 1 tablet 8 hourly |
Clavumed 625 | 1 tablet 8 hourly | 1 tablet 8 hourly | 1 tablet 8 hourly | 1 tablet 8 hourly |
Amoxicillin-Resistant Organisms | ||||
---|---|---|---|---|
Product | Upper Respiratory Tract Infection (Otitis media) | Lower Respiratory Tract Infection (Bronchitis) | Urinary Tract Infection | Skin & Soft Tissue Infections |
Clavumed 375 | - | - | 1 tablet 8 hourly | 1 tablet 8 hourly |
Clavumed 625 | 1 tablet 8 hourly | 1 tablet 8 hourly | 1 tablet 8 hourly | 1 tablet 8 hourly |
For oral use.
In overdose, side effects can be precipitated and/or be of increased severity (see section 4.8).
24 months.
Store at or below 25°C, protected from light and moisture.
KEEP OUT OF REACH OF CHILDREN.
Clavumed 375:
Aluminium strip pack containing 15 and 100 tablets in a carton.
Clavumed 625:
Aluminium strip pack containing 15 tablets in a carton.
Any unused medicine or waste material should be disposed of in accordance with local requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.